A normal heart beat occurs whenever there is a coordinated progression of electrical impulses. Sinoatrial node (SA node), also known as the heart’s natural pacemaker sends out the electrical impulses which will make the atrium and ventricles contract and push blood throughout the body. Any disruption to this electrical impulse generation and transmission results in symptomatic heart valve disease treatment, abnormal heart rhythms and is termed asarrhythmia. In some cases, the erratic impulses are produced by any other heart muscle in the atria that overrides the functioning of the heart’s natural pacemaker. This leads to the fibrillation of atria, further resulting in
excessively higher or abnormal heart rates and the condition is termed as atrial fibrillation (AF) or AFib. Evaluating the symptoms and seeking the right atrial fibrillation treatment is essential to reduce the risks of stroke and heart failure.
Erroneous electrical signals sent from the atria leads to the disorganized contractions of heart chambers. Irregular contraction of atria and ventricles leads to an abnormally faster heartbeat thereby reducing the heart’s efficiency and performance. Moreover, the chaotic rhythm in the atria causes disturbances in the blood flow. This sometimes leads to blood clot formation, which can travel to the brain, resulting in stroke. People with AF are at a higher risk of having embolic stroke and heart failures. That is why it is always recommended to opt for the most helpful form of right atrial fibrillation treatment. AFib
patients with higher or moderate risk of developing a blood clot are prescribed with medications, catheter-based procedures or surgery. Stroke prevention in atrial fibrillation is possible only by cutting down the chances of blood clot formation.
Depending on the level of risk and assessment of your symptoms, anticoagulant medicines are prescribed by the physicians. Vitamin K antagonists have been used as the standard therapeutic option for stroke prevention in atrial fibrillation patients. Warfarin, dabigatram, rivaroxaban and apixaban are some of the commonly used blood thinning medicines. Preventing the abnormalities in heart rate is also important for the symptomatic heart valve disease treatment. Depending on the severity of Afib episodes, underlying cardiac issues and the symptoms, the physician will determine the best risk stratification strategy.
